• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个控制核因子-κB亚基活性和功能的细胞周期调控网络。

A cell cycle regulatory network controlling NF-kappaB subunit activity and function.

作者信息

Barré Benjamin, Perkins Neil D

机构信息

Division of Gene Regulation and Expression, College of Life Sciences, University of Dundee, Dundee, Scotland, UK.

出版信息

EMBO J. 2007 Nov 28;26(23):4841-55. doi: 10.1038/sj.emboj.7601899. Epub 2007 Oct 25.

DOI:10.1038/sj.emboj.7601899
PMID:17962807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2099464/
Abstract

Aberrantly active NF-kappaB complexes can contribute to tumorigenesis by regulating genes that promote the growth and survival of cancer cells. We have investigated NF-kappaB during the cell cycle and find that its ability to regulate the G1-phase expression of key proto-oncogenes is subject to regulation by the integrated activity of IkappaB kinase (IKK)alpha, IKKbeta, Akt and Chk1. The coordinated binding of NF-kappaB subunits to the Cyclin D1, c-Myc and Skp2 promoters is dynamic with distinct changes in promoter occupancy and RelA(p65) phosphorylation occurring through G1, S and G2 phases, concomitant with a switch from coactivator to corepressor recruitment. Akt activity is required for IKK-dependent phosphorylation of NF-kappaB subunits in G1 and G2 phases, where Chk1 is inactive. However, in S-phase, Akt is inactivated, while Chk1 phosphorylates RelA and associates with IKKalpha, inhibiting the processing of the p100 (NF-kappaB2) subunit, which also plays a critical role in the regulation of these genes. These data reveal a complex regulatory network integrating NF-kappaB with the DNA-replication checkpoint and the expression of critical regulators of cell proliferation.

摘要

异常激活的核因子-κB复合物可通过调控促进癌细胞生长和存活的基因来促进肿瘤发生。我们研究了细胞周期中的核因子-κB,发现其调控关键原癌基因G1期表达的能力受到IκB激酶(IKK)α、IKKβ、Akt和Chk1整合活性的调节。核因子-κB亚基与细胞周期蛋白D1、c-Myc和Skp2启动子的协同结合是动态的,在G1、S和G2期启动子占据和RelA(p65)磷酸化发生明显变化,同时伴随着从共激活因子募集到共抑制因子募集的转变。在G1和G2期,Chk1无活性,Akt活性是IKK依赖的核因子-κB亚基磷酸化所必需的。然而,在S期,Akt失活,而Chk1使RelA磷酸化并与IKKα结合,抑制p100(核因子-κB2)亚基的加工,p100亚基在这些基因的调控中也起关键作用。这些数据揭示了一个复杂的调控网络,将核因子-κB与DNA复制检查点及细胞增殖关键调节因子的表达整合在一起。

相似文献

1
A cell cycle regulatory network controlling NF-kappaB subunit activity and function.一个控制核因子-κB亚基活性和功能的细胞周期调控网络。
EMBO J. 2007 Nov 28;26(23):4841-55. doi: 10.1038/sj.emboj.7601899. Epub 2007 Oct 25.
2
Regulation and function of IKK and IKK-related kinases.IKK及IKK相关激酶的调控与功能
Sci STKE. 2006 Oct 17;2006(357):re13. doi: 10.1126/stke.3572006re13.
3
Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38.Akt通过利用IκB激酶并激活丝裂原活化蛋白激酶p38来刺激NF-κB的RelA/p65亚基的反式激活潜能。
J Biol Chem. 2001 Jun 1;276(22):18934-40. doi: 10.1074/jbc.M101103200. Epub 2001 Mar 20.
4
Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit.p52核因子-κB亚基对p53肿瘤抑制靶基因表达的调控
EMBO J. 2006 Oct 18;25(20):4820-32. doi: 10.1038/sj.emboj.7601343. Epub 2006 Sep 21.
5
Regulation of I(kappa)B kinase complex by phosphorylation of (gamma)-binding domain of I(kappa)B kinase (beta) by Polo-like kinase 1.Polo样激酶1对IκB激酶β的γ结合结构域进行磷酸化从而调控IκB激酶复合物
J Biol Chem. 2008 Dec 19;283(51):35354-67. doi: 10.1074/jbc.M806258200. Epub 2008 Oct 27.
6
Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer.异常激活的 IKKα 和 IKKβ 协同作用激活 NF-κB,并诱导 EGFR/AP1 信号通路促进头颈部癌症的存活和迁移。
Oncogene. 2014 Feb 27;33(9):1135-47. doi: 10.1038/onc.2013.49. Epub 2013 Mar 4.
7
Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.PKR的基因缺失消除了肿瘤坏死因子诱导的IκBα激酶、JNK、Akt激活以及细胞增殖,但增强了p44/p42丝裂原活化蛋白激酶(MAPK)和p38 MAPK的激活。
Oncogene. 2007 Feb 22;26(8):1201-12. doi: 10.1038/sj.onc.1209906. Epub 2006 Aug 21.
8
Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia.Notch3与前T细胞受体的相互作用揭示了T细胞发育和白血病中不同的核因子κB信号通路。
EMBO J. 2006 Mar 8;25(5):1000-8. doi: 10.1038/sj.emboj.7600996. Epub 2006 Feb 23.
9
IKK-i/IKKepsilon controls constitutive, cancer cell-associated NF-kappaB activity via regulation of Ser-536 p65/RelA phosphorylation.IKK-i/IKKε 通过调控 Ser-536 p65/RelA 磷酸化来控制组成性的、与癌细胞相关的 NF-κB 活性。
J Biol Chem. 2006 Sep 15;281(37):26976-84. doi: 10.1074/jbc.M603133200. Epub 2006 Jul 13.
10
NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug.NF-κB 在 AKT 依赖性方式下被替莫唑胺激活,并赋予对药物生长抑制作用的保护作用。
J Transl Med. 2012 Dec 21;10:252. doi: 10.1186/1479-5876-10-252.

引用本文的文献

1
Design and Synthesis of Novel Aminoindazole-pyrrolo[2,3-]pyridine Inhibitors of IKKα That Selectively Perturb Cellular Non-Canonical NF-κB Signalling.新型氨基吲唑-吡咯并[2,3-d]嘧啶 IKKα 抑制剂的设计与合成,该抑制剂可选择性干扰细胞非经典 NF-κB 信号通路。
Molecules. 2024 Jul 26;29(15):3515. doi: 10.3390/molecules29153515.
2
Structures of NF-κB p52 homodimer-DNA complexes rationalize binding mechanisms and transcription activation.NF-κB p52 同源二聚体-DNA 复合物的结构阐明了结合机制和转录激活。
Elife. 2023 Feb 13;12:e86258. doi: 10.7554/eLife.86258.
3
Cyclin-dependent kinase 7/9 inhibitor SNS-032 induces apoptosis in diffuse large B-cell lymphoma cells.周期蛋白依赖性激酶 7/9 抑制剂 SNS-032 诱导弥漫性大 B 细胞淋巴瘤细胞凋亡。
Cancer Biol Ther. 2022 Dec 31;23(1):319-327. doi: 10.1080/15384047.2022.2055421.
4
Origin of the Functional Distinctiveness of NF-κB/p52.NF-κB/p52功能独特性的起源
Front Cell Dev Biol. 2021 Nov 23;9:764164. doi: 10.3389/fcell.2021.764164. eCollection 2021.
5
PKCδ/MAPKs and NF-κB Pathways are Involved in the Regulation of Ingenane-Type Diterpenoids from on Macrophage Function.蛋白激酶Cδ/丝裂原活化蛋白激酶和核因子κB信号通路参与了土沉香烷型二萜对巨噬细胞功能的调节。
J Inflamm Res. 2021 Jun 25;14:2681-2696. doi: 10.2147/JIR.S306846. eCollection 2021.
6
FKBP4 integrates FKBP4/Hsp90/IKK with FKBP4/Hsp70/RelA complex to promote lung adenocarcinoma progression via IKK/NF-κB signaling.FKBP4 将 FKBP4/Hsp90/IKK 与 FKBP4/Hsp70/RelA 复合物整合在一起,通过 IKK/NF-κB 信号通路促进肺腺癌的进展。
Cell Death Dis. 2021 Jun 10;12(6):602. doi: 10.1038/s41419-021-03857-8.
7
Glycogen synthase kinase (GSK)-3 and the double-strand RNA-dependent kinase, PKR: When two kinases for the common good turn bad.糖原合酶激酶(GSK)-3 和双链 RNA 依赖性激酶,PKR:当两种激酶为了共同的利益而变得糟糕。
Biochim Biophys Acta Mol Cell Res. 2020 Oct;1867(10):118769. doi: 10.1016/j.bbamcr.2020.118769. Epub 2020 Jun 5.
8
Role of Nuclear Factor Kappa B (NF-κB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach.核因子 κB(NF-κB)信号通路在神经退行性疾病中的作用:一种机制方法。
Curr Neuropharmacol. 2020;18(10):918-935. doi: 10.2174/1570159X18666200207120949.
9
The Screening Research of NF-B Inhibitors from Moutan Cortex Based on Bioactivity-Integrated UPLC-Q/TOF-MS.基于生物活性整合的超高效液相色谱-四极杆/飞行时间质谱联用技术对牡丹皮中NF-κB抑制剂的筛选研究
Evid Based Complement Alternat Med. 2019 Mar 3;2019:6150357. doi: 10.1155/2019/6150357. eCollection 2019.
10
Overexpression of LASS2 inhibits proliferation and causes G0/G1 cell cycle arrest in papillary thyroid cancer.LASS2的过表达抑制甲状腺乳头状癌的增殖并导致G0/G1期细胞周期阻滞。
Cancer Cell Int. 2018 Oct 1;18:151. doi: 10.1186/s12935-018-0649-1. eCollection 2018.

本文引用的文献

1
The selectivity of protein kinase inhibitors: a further update.蛋白激酶抑制剂的选择性:进一步更新
Biochem J. 2007 Dec 15;408(3):297-315. doi: 10.1042/BJ20070797.
2
Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin.核因子激活的IKKα通过抑制Maspin来控制前列腺癌转移。
Nature. 2007 Apr 5;446(7136):690-4. doi: 10.1038/nature05656. Epub 2007 Mar 18.
3
Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression.细胞周期蛋白D1作为癌基因的功能及细胞周期蛋白D1表达的调控。
Cancer Sci. 2007 May;98(5):629-35. doi: 10.1111/j.1349-7006.2007.00449.x. Epub 2007 Mar 14.
4
Integrating cell-signalling pathways with NF-kappaB and IKK function.整合细胞信号通路与核因子-κB及IκB激酶功能
Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62. doi: 10.1038/nrm2083.
5
Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway.调节核因子κB信号通路活性和功能的翻译后修饰
Oncogene. 2006 Oct 30;25(51):6717-30. doi: 10.1038/sj.onc.1209937.
6
NFkappaB1/p50 is not required for tumor necrosis factor-stimulated growth of primary mammary epithelial cells: implications for NFkappaB2/p52 and RelB.原发性乳腺上皮细胞的肿瘤坏死因子刺激生长不需要NFkappaB1/p50:对NFkappaB2/p52和RelB的影响
Endocrinology. 2007 Jan;148(1):268-78. doi: 10.1210/en.2006-0500. Epub 2006 Sep 28.
7
Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit.p52核因子-κB亚基对p53肿瘤抑制靶基因表达的调控
EMBO J. 2006 Oct 18;25(20):4820-32. doi: 10.1038/sj.emboj.7601343. Epub 2006 Sep 21.
8
Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase.有证据表明,ATR/Chk1通路在未受干扰的S期维持正常的复制叉进展。
Cell Cycle. 2006 Oct;5(19):2203-9. doi: 10.4161/cc.5.19.3256. Epub 2006 Oct 1.
9
IKKalpha controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression.IKKα在Skp2基因启动子处调控p52/RelB,以调节G1期到S期的进程。
EMBO J. 2006 Aug 23;25(16):3801-12. doi: 10.1038/sj.emboj.7601259. Epub 2006 Aug 10.
10
Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.Cyld通过阻断Bcl-3依赖的NF-κB信号传导来抑制肿瘤细胞增殖。
Cell. 2006 May 19;125(4):665-77. doi: 10.1016/j.cell.2006.03.041.